Expression of proliferation-associated nuclear autoantigens, p330d/CENP-F and PCNA, in differentiation and in drug-induced growth inhibition using two-parameter flow cytometry.

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

1984 • 4,180 citations

DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS

1989 • 1,799 citations

Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ

1987 • 1,766 citations

Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein

1987 • 1,074 citations

Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.

1983 • 978 citations

Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites.

1987 • 945 citations

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

1991 • 891 citations

Autoantibody to a Nuclear Antigen in Proliferating Cells

1978 • 881 citations

Proliferating cell nuclear antigen is required for DNA excision repair

1992 • 809 citations

Autoantibodies in the diagnosis of systemicrheumatic diseases

1995 • 564 citations

Regulation of Proliferating Cell Nuclear Antigen during the Cell Cycle

1989 • 447 citations

CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis.

1995 • 367 citations

Eukaryotic DNA topoisomerases I

1995 • 307 citations

Ki-67 detects a nuclear matrix-associated proliferation-related antigen: II. Localization in mitotic cells and association with chromosomes

1989 • 263 citations

Ki-67 detects a nuclear matrix-associated proliferation-related antigen : I. Intracellular localization during interphase

1989 • 223 citations

CENP‐F is a ca 400 kDa kinetochore protein that exhibits a cell‐cycle dependent localization

1993 • 220 citations

Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera.

1984 • 189 citations

Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis.

1991 • 152 citations

Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67

1986 • 150 citations

Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications

1993 • 129 citations

Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation‐associated antibody Ki‐67 and propidium iodide: analysis by flow cytometry

1987 • 100 citations

Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.

1990 • 93 citations

Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis

1993 • 79 citations

Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation

1995 • 66 citations

Retinoic acid‐induced differentiation of the human promyelocytic leukemia cell line, HL‐60, and fresh human leukemia cells in primary culture: A model for differentiation inducing therapy of leukemia

1987 • 65 citations

Cell cycle-dependent reactivity with the monoclonal antibody Ki-67 during myeloid cell differentiation

1988 • 62 citations

The cell cycle: myths and realities.

1990 • 49 citations

Proliferating cell nuclear antigen and Ki‐67 antigen expression in human haematopoietic cells during growth stimulation and differentiation

1993 • 38 citations

S-Phase Population Analysis Does Not Correlate with the Cytotoxicity of Camptothecin and 10,11-Methylenedioxycamptothecin in Human Colon Carcinoma HT-29 Cells

1991 • 34 citations

Effects of the antitumor drugs 3-nitrobenzothiazolo {3,2-a}quinolinium and fagaronine on nucleic acid and protein synthesis

1986 • 31 citations

Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.

1990 • 18 citations

Clinical applications of serum and tissue markers in malignant disease: breast cancer as the paradigm

1993 • 15 citations

Cell Cycle-Associated Autoantibodies: Markers for Autoimmunity and Probes for Molecular Cell Biology

1994 • 15 citations

Different Modes of Cell‐killing Action between DNA Topoisomerase I and II Inhibitors Revealed by Kinetic Analysis

1994 • 14 citations

Topoisomerase inhibitors potentiate the effect of retinoic acid on cell growth inhibition and induction of differentiation of leukemia HL-60 cells

1994 • 13 citations

The antitumor drug 3-nitrobenzothiazolo(3,2-a)quinolinium chloride (NBQ): effects on lens regeneration and interaction with DNA of Notophthalmus viridescens

1987 • 12 citations

Myeloid differentiation of HL-60 cells induced by anti-tumor drug 3-nitrobenzothiazolo[3,2-a]quinolinium

1992 • 11 citations

Effects of 3-nitrobenzothiazolo [3,2-a] quinolinium chloride (NBQ) and doxorubicin on lens regeneration in the adult newt: a morphological study

1994 • 10 citations